FIELD: pharmaceutical industry. SUBSTANCE: medicinal form of metronidazole contains water (solvent), dimethylacetamide, phosphate-citrate buffer, and, additionally, polyvinylpyrrolidone Attention: as complexing agent and preservative at specified proportions. Composition can also be completed by propylene glycol as cosolvent. Preservative can be represented, for example, by benzyl alcohol and/or methyl(propyl)paraben. EFFECT: prolonged curative effect allowing number of injections to be reduced. 2 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AQUEOUS-DISPERSED MEDICINAL FORM OF IVERMECTIN FOR TREATMENT OF ECTO- AND ENDOPARASITOSIS | 2000 |
|
RU2162699C1 |
| COMPOSITION FOR TREATING BACTERIAL INFECTIONS IN ANIMALS | 2009 |
|
RU2397753C1 |
| METHOD FOR PREPARING METRONIDASOL SOLUTION FOR INJECTIONS | 2003 |
|
RU2245135C1 |
| INJECTION MEDICINAL FORMULATION FOR TREATMENT AND PROPHYLAXIS OF BLOOD-PARASITIC AND INVASION DISEASES | 2005 |
|
RU2296568C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASES OF BACTERIAL AND PARASITIC ETIOLOGY | 2003 |
|
RU2273480C2 |
| ADJUVANT FOR BIOPREPARATIONS | 2002 |
|
RU2214278C1 |
| ANTIBACTERIAL INJECTABLE PHARMACEUTICAL COMPOSITION | 2012 |
|
RU2512683C2 |
| SYNERGISTIC SUPPOSITORIES FOR INFECTIOUS GYNECOPATHIES TREATMENT (VERSIONS) | 2007 |
|
RU2356535C2 |
| ANTISEPTIC PHARMACEUTICAL COMPOSITION, METHOD OF ITS PRODUCTION AND APPLICATION | 2008 |
|
RU2404744C2 |
| METHOD TO OBTAIN COMPOSITION OF OXYTETRACYCLINE MAGNESIUM COMPLEX OF PROLONGED ACTION | 2000 |
|
RU2178698C1 |
